SELECTMD reports nine months net profit of $24.63 million

November 15, 2022

Sagicor Select Fund Manufacturing & Distribution (SELECTMD)

For the nine months ended September 30, 2022: –

Sagicor Select Fund Manufacturing & Distribution (SELECTMD) for the nine months ended September 30, 2022 reported dividend income of $79.48 million (2021: $68.01 million). Interest income closed the nine months period at $1.13 million and relative to $1.09 million last year.

Net changes in fair value on financial assets at fair value through P&L for the nine month period amounted to a loss $29.87 million compared to a gain of $922.49 million booked in 2021.

Net Investment income amounted to $50.73 million relative to $991.59 million booked last year.

Net foreign currency gains and other income amounted to $223,000 (2021: $60,000).

As such, total revenue for the nine months under review equated to $50.96 million relative to $991.65 million the previous year. The total income for the quarter amounted to a loss of $281.27 million relative to a total income of $18.52 million twelve months earlier.

Total expenses for the nine months period closed at $26.32 million (2021: $23.29 million), while for the quarter, expenses amounted to $7 million (2021: $8.62 million).

Consequently, net profit closed the nine months period at $24.63 million relative to $968.35 million last year. Whereas the quarter net loss amounted to $288.27 million versus the net profit of $9.89 million booked last year.

Earnings per share for the period under review amounted to $0.01 relative to $0.25 in 2021, while for the quarter, SelectMD booked a loss per share (LPS) of $0.076 versus an EPS of $0.0026 in 2021. Twelve-month trailing LPS was $0.02. The number of shares used in this calculation was 3,816,612,000 shares. As at November 14, 2022 the stock traded at $0.57.

SELECTMD reported that, “During the nine months to September 2022, the fund saw a fair value loss on its financial assets of $29.9 million, owing to price depreciation in manufacturing and distribution companies.”


Balance Sheet Highlights:

Total assets, as at September 30, 2022, amounted to $4.11 billion (2021: $4.21 billion). Of this, Financial assets at fair value through profit or loss totalled $3.88 billion (2021: $4.14 billion).

Total equity as at September 30, 2022 amounted to $4.09 billion (2021: $4.19 billion), resulting in a net asset value per share of $1.07 (2020: $1.10).




Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.